Clinical Trials Directory

Trials / Unknown

UnknownNCT05421468

Timing of Thyroxine Dose In Ramadan

Timing of Thyroxine Dose In Ramadan; a Randomized Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
King Abdullah International Medical Research Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A Randomized trial comparing two different timing of taking thyroxine in patients with Hypothyroidism during fasting the month of Ramadan.

Detailed description

To date there is debate regarding the best timing of L-thyroxine administration during Ramadan as sufficient evidence is lacking. This study aims to compare two-time points of levothyroxine intake during Ramadan focusing on change in TSH, satisfaction and compliance. A prospective, randomized, open label, multicenter Study. The first group will be will be instructed to take their L-thyroxin dose as per current guidlines at breaking of fast time (sunset) with sip of water then wait 30-60 minutes to consume Iftar meal. The second group (pre-Fajer prayer), patients are going to be instructed to take L-thyroxin dose immediately before start of fast, i.e. Alfajer (dawn) regardless of Suhoor time. The values of Thyroid stimulating hormone (TSH) will be measured two weeks before Ramadan, and 2-4 weeks after Ramadan for comparison.

Conditions

Interventions

TypeNameDescription
OTHERL-Thyroxine time B (5-15 minutes Before dawn)Taking thyroxine at two different time points in relation to fasting and food intake; just before dawn and start of fast compared to the usual timing of 30-60minutes after the sunset breakfast meal.

Timeline

Start date
2022-03-14
Primary completion
2022-08-30
Completion
2022-10-30
First posted
2022-06-16
Last updated
2022-06-16

Locations

2 sites across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT05421468. Inclusion in this directory is not an endorsement.